Nolato ABFRA:NBF +4.55%75 Days Payable is 30.31 as of Mar. 2026, which is 24% below its 10-year median of 39.80. GuruFocus rates FRA:NBF with a GF Score™ of 75/100 and a GF Value™ of €4.74 (Fairly Valued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Nolato AB ranks worse than 82.77% on this metric.
Nolato AB's average Accounts Payable for the
three
months ended in Mar. 2026 was €59.4 Mil. Nolato AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €178.7 Mil.
Hence, Nolato AB's Days Payable for the
three
months ended in Mar. 2026 was 30.31.
The historical rank and industry rank for Nolato AB's Days Payable or its related term are showing as below:
FRA:NBF'
s Days Payable Range Over the Past 10 Years
Min: 30.01 Med: 39.8 Max: 61.5
Current: 32.19
During the past 13 years, Nolato AB's highest Days Payable was 61.50. The lowest was 30.01. And the median was 39.80.
FRA:NBF's Days Payable is ranked worse than 82.77% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:NBF: 32.19
Nolato AB's Days Payable
declined
from Mar. 2025 (30.54) to Mar. 2026 (30.31).
It may suggest that Nolato ABaccelerated paying its suppliers.
Nolato AB Days Payable Related Terms
Nolato AB Days Payable Historical Data
* Premium members only.
The historical data trend for Nolato AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nolato AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Nolato AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Nolato AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (FRA:NBF) has a Days Payable of 30.31 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nolato AB and its competitors. This is 24% below median its historical median of 39.80. Over the past decade, Nolato AB's Days Payable has ranged from 30.01 to 61.50. According to the industry distribution chart, Nolato AB ranks #658 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 82.8%.
Is Nolato AB's Days Payable too high?
Nolato AB's current Days Payable of 30.31 is 24% below median its 10-year median of 39.80. Over the past 10 years, this metric has ranged from a low of 30.01 to a high of 61.50. The Medical Devices & Instruments industry median Days Payable is 68.07. Nolato AB's value of 30.31 is 55.5% below this industry median. Based on the distribution chart, Nolato AB ranks #658 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nolato AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #658 out of 795 companies for Days Payable. This places Nolato AB in the lower half of its industry. The industry median Days Payable is 68.07. Nolato AB's value of 30.31 is 55.5% below this benchmark. Historically, Nolato AB's own Days Payable has ranged from 30.01 to 61.50 over the past decade. While the company's 10-year median is 39.80 vs. the industry median of 68.07, Nolato AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nolato AB's current Days Payable of 30.31 is 55.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nolato AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nolato AB's current Days Payable is 30.31, which is 24% below median its own 10-year median of 39.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Fairly Valued. The stock's GF Value™ is €4.74, compared to a current price of €4.48 — trading 5.5% below its estimated fair value. The current Days Payable is 30.31, which is 24% below median its 10-year median of 39.80 and 55.5% below the Medical Devices & Instruments industry median of 68.07. Nolato AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current Days Payable is 30.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (FRA:NBF) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of €4.48 is trading 5.5% below its estimated GF Value™ of €4.74.
GuruFocus considers Nolato AB to be Fairly Valued.
Key valuation signals for FRA:NBF:
Days Payable: 30.31 (24% below median its 10-year median of 39.80)
GF Value™: €4.74 vs. price of €4.48 (5.5% below fair value)
Industry Position: 55.5% below the Medical Devices & Instruments median (#658 of 795)
No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
75GF Score
Get the complete analysis for FRA:NBF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NBF has been successfully added to your 
